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Abstract  
Zinc is integral for the normal function of pancreatic β-cells in glycaemic control. Large 
amounts of zinc are secreted from β-cells following insulin exocytosis and regulated 
replenishment is required, which is thought to be mediated by the ZIP family of zinc importer 
proteins. Within type 2 diabetic patients, β-cells are stressed through prolonged stimulation by 
hyperglycaemia and this is thought to be a major factor contributing to loss of β-cell identity 
and mass. However, the consequences for the β-cell zinc status remain largely unexplored. We 
used inductively coupled plasma mass spectrometry (ICP-MS) to show that 24 h treatment of 
MIN6 cells with potassium chloride, mimicking hyperglycaemic stimulation, reduces the total 
cellular zinc content 2.8-fold, and qPCR to show an increase in mRNA expression for 
metallothioneins (Mt1 and Mt2) following 4 and 24 h of stimulation, suggestive of an early rise 
in cytosolic zinc. To determine which ZIP paralogues may be responsible for zinc 
replenishment, we used immunocytochemistry, western blot and qPCR to demonstrate initial 
ZIP1 protein upregulation proceeded by downregulation of mRNA coding for ZIP1, ZIP6, 
ZIP7 and ZIP14. To assign a biological significance to the decreased total cellular zinc content, 
we assessed expression of key β-cell markers to show downregulation of mRNA for MafA, 
Mnx-1, Nkx2.2 and Pax6. Our data suggest hyperglycaemia-induced zinc depletion may 
contribute to loss of β-cell identity and promote β-cell dedifferentiation through disrupting 
expression of key transcription factors. 
 
 
 
 
 
 
AC
CE
PT
ED
 M
AN
US
CR
IPT
3 
 
Keywords 
Zinc  
β-cells 
ZIP transporters  
Transcription factors  
Gene expression 
Dedifferentiation  
 
Abbreviations  
Zn2+: zinc ions, MT: metallothionein, ZIP: Zrt- and Irt-related protein, ZnT: zinc transporter 
protein, GSIS: glucose-stimulated insulin secretion, KATP channels: ATP-sensitive potassium  
channels, L-VGCC: L-type voltage-gated calcium channels, Ca2+: calcium ions, TRP: transient 
receptor potential, qPCR: quantitative PCR, ICP-MS: inductively-coupled plasma mass 
spectrometry, MODY: maternity-onset diabetes of the young, MRE: metal response element. 
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Introduction  
Zinc is an essential micronutrient in mammalian physiology and human health. Links between 
zinc and diabetes were first established in 1938 [1], and a hypozincaemic status have since 
been described in some type 2 diabetic patients [2,3] and in animal models of diabetes [4,5]. 
Roles of both environmental and genetic contributors to Type 2 Diabetes pathogenesis and 
progression have been extensively documented, and estimates for heritability range from 30-
70% [6,7].  
 
Zinc is a structural, catalytic, and regulatory component of proteins within and outside cells 
[8]. Even at very low concentrations the free zinc ions (Zn2+) exhibit potent effects [9,10]. 
Intracellular Zn2+ concentrations are therefore tightly regulated to mediate physiological targets 
whilst avoiding cross-metal interference [11]. Cells maintain intracellular Zn2+ concentrations 
through buffering and muffling (time-dependent redistribution through intracellular 
compartmentalisation) dynamics, which vary dependent on cellular state [12]. Buffering is 
mediated by metallothionein (MT1-4) zinc-binding proteins. MT mRNA levels are rapidly 
increased in response to a rise in cytosolic Zn2+, primarily driven by activation of the Zn2+-
sensing transcription factor MTF1, which regulates expression of genes involved in 
intracellular zinc homeostasis [13]. Translocation of Zn2+ across biological membranes is 
mediated by the Zrt- and Irt-related protein (ZIP; SLC39A) and the zinc transporter protein 
(ZnT; SLC30A) families of zinc transporters, which move zinc into and out of the cytosol, 
respectively. In humans and rodents, 14 ZIP and 10 ZnT paralogues exist [14,15], varying in 
terms of tissue distribution, cytolocation, zinc-affinities, transporting efficiencies and 
regulatory mechanisms to tightly and specifically deliver zinc to different cell-types and 
organelles [14,16].  
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Type 2 Diabetes is a chronic metabolic disease characterised by hyperglycaemia proceeding to 
loss of insulin-secreting pancreatic β-cells through apoptosis and dedifferentiation to a 
progenitor-like state [17-19]. Critically, zinc is integral for β-cell function in glycaemic control 
[20,21]. β-cells maintain total zinc concentrations at 150-200µM, of which 70% is contained 
within insulin secretory granules at much higher concentrations [22]. Zinc is loaded into 
granules via the predominantly β-cell-specific zinc transporter 8 (ZnT8) [9,23], where two Zn2+ 
bind insulin hexamers, essential for proper insulin processing and granule maturation [24]. 
High concentrations of extracellular glucose (16.7-22.2mM [25]) stimulate signalling cascades 
resulting in Zn2+ and insulin co-release from β-cell granules [26,27], known as glucose-
stimulated insulin secretion (GSIS). The GSIS pathway involves metabolism of glucose 
through glycolysis to elevate the ATP/ADP ratio, which agonises ATP-sensitive potassium ion 
(K+) channels (KATP channels) to promote membrane depolarisation, activation of L-type 
voltage-gated calcium channels (L-VGCC), resulting in calcium ion (Ca2+) and Zn2+ influx 
[28], membrane fusion of granules and insulin exocytosis [29]. ZnT8 is a recognised Type 2 
Diabetes risk locus at which an arginine to tryptophan substitution polymorphism confers a 
~14% increase in risk per arginine risk allele [30,31]. Rare loss-of-function ZnT8 
polymorphisms are protective against Type 2 Diabetes [32], highlighting the complex 
relationship between zinc trafficking and β-cell function. An adequate zinc status is further 
important for maintaining the intracellular redox balance, signalling pathways linked to β-cell 
mass [33], and is associated in zebrafish with expression of transcription factors (neurod1, 
hnf1ß, hnf4α, foxa1, nkx2.2, and pax6) required for ß-cell differentiation and endocrine 
function [34-37]. A recent study using human insulin-secreting β-cell like stem cells 
additionally showed zinc supplementation induces up-regulation of the β-cell markers PDX1 
and PAX4 [38]. Thus, there might be a link between zinc dysregulation in β-cells during 
diabetes and loss of β-cell phenotype and associated endocrine function. 
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Hyperglycaemia is universal in all type 2 diabetic patients and contributes to loss of β-cell mass 
through promoting β-cell dedifferentiation [18]; prolonged stimulation of the GSIS pathway is 
therefore characteristic of Type 2 Diabetic pathology. β-cells exhibit an exceptionally high 
turnover of zinc to maintain homeostatic control over zinc concentrations following insulin 
granule exocytosis, and replenishment is required to maintain intracellular homeostasis [39]. 
High glucose stimulation of mouse islets for 24 h has previously been shown to double 
cytosolic free Zn2+ concentrations and to up-regulate genes involved in cellular zinc 
homeostasis [40] including ZIP6 and ZIP7 [41,42]. However, the consequences of chronic 
hyperglycaemia for β-cell zinc content remains poorly understood and experimental 
exploration of the ZIP paralogues in β-cell function remains limited to a few studies [40,43-
46]. We have previously shown through a systematic review complemented with experimental 
data that ZIP6, ZIP7, ZIP9 and ZIP14 in human and rodent, and ZIP1 in rodent are potentially 
biologically important for β-cell zinc trafficking [46]. Here, we postulated these ZIP paralogues 
are involved in intracellular zinc homeostasis during β-cell stimulation. We also hypothesised 
that prolonged stimulation may lead to cellular zinc loss through enhanced zinc/insulin co-
secretion, and that this may affect expression of β-cell markers, which as a consequence could 
influence β-cell phenotype. Thus, the aim of the present study was to characterise the 
consequences of prolonged stimulation for β-cell zinc content and expression of key ZIP 
transporters and zinc-responsive β-cell markers.  
 
We show that prolonged stimulation decreases the total zinc content of MIN6 cells but 
increases mRNA expression for Mt1 and Mt2, indicative of an early surge in cytosolic Zn2+ 
followed by increased buffering capacity as MT1 and MT2 proteins are being produced [47]. 
Unexpectedly, this effect on MT was coupled with a decrease in Mtf1 mRNA. Using a 
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combination of quantitative PCR (qPCR), immunocytochemistry and western blot, we 
observed an increase in ZIP1 and a decrease in ZIP7 protein, down-regulation of mRNA for 
Slc39a1, Slc39a6, Slc39a7, Slc39a14, and down-regulation of multiple zinc-responsive β-cell 
markers. Our data demonstrate that prolonged stimulation depletes β-cells of zinc, presumably 
as a result of a decrease of multiple ZIP transporters along with loss of gene expression of 
several markers of β-cell differentiation. 
 
Methods and Materials  
Cell line and culture  
The adherent insulinoma β-cell line MIN6 (Mus musculus) was a kind gift from Dr. Jun-ichi 
Miyazaki [48]. Cells were maintained within 25mM glucose Dulbecco’s Modified Eagle’s 
Medium (DMEM) supplemented with 15% foetal bovine serum (FBS), 4mM L-glutamine, 
50μM β-mercaptoethanol, 100μg/ml streptomycin and 100 units/ml penicillin (both Thermo 
Fisher) at 37oC in a humidified atmosphere of 95% air and 5% CO2. Cells were cultured for 24 
h prior to experimentation. For cell stimulation: growth media was replaced with glucose-free 
DMEM containing 15% FBS, 4mM L-glutamine, 50μM β-mercaptoethanol, 100μg/ml 
streptomycin and 100 units/ml penicillin supplemented with either 3mM glucose (control) or 
3mM glucose and 40mM potassium chloride (KCl) for 4 h or 24 h. KCl was used to depolarise 
MIN6 cells to induce insulin secretion since the cells were not glucose-responsive. For zinc 
depletion: FBS was depleted of metal ions through incubation with 5% (w/v) Chelex-100 
(Sigma) for 1 h, and sterile-filtered through a 0.22μm syringe filter. Chelex-100 treated FBS 
was diluted 1:100 in 0.5% nitric acid (HNO3) and heavy metal analysis carried out through 
inductively-coupled plasma mass spectrometry (ICP-MS) [49]. Chelex-100 treated FBS was 
supplemented with Ca2+, K+ and Na+ to original concentrations. Growth media were replaced 
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with 25mM glucose DMEM containing 15% Chelex-100 treated-FBS, 4mM L-glutamine, 
50μM β-mercaptoethanol, 100μg/ml streptomycin and 100 units/ml penicillin, supplemented 
with ZnCl2 to total concentrations of 1µM or 8µM (control) Zn
2+ for 24, 48 or 96 h.  
 
Determination of total zinc content  
Cells were lysed in hot 0.2% sodium dodecyl sulfate (SDS). Samples were diluted 1:100 with 
0.5% HNO3 (trace element grade) and the zinc concentration determined through ICP-MS. The 
total zinc content was normalised to protein content, determined through Bradford assays (Bio-
Rad) [50], which were standardised to dilutions of bovine serum albumin (BSA) in phosphate-
buffered saline (PBS). Statistical significance of differences in cellular zinc content was 
examined through unpaired t-tests. 
 
RNA extraction, cDNA synthesis and quantitative PCR 
Total RNA was extracted using TRIzol Reagent (Thermo Fisher), reverse transcribed to cDNA 
using the high capacity RNA-to-cDNA kit (Thermo Fisher), and diluted ≥1:10 prior to 
experimentation. Quantitative PCR (qPCR) assays were designed using the online Universal 
Probe Library (UPL) assay design tool (Roche). Assay designs are provided in Additional file 
1. PCR plates were loaded using the Biomek FX liquid handling robot (Beckman Coulter) and 
reactions (20-40ng cDNA, 0.1µM UPL probe, 0.2µM forward primer, 0.2µM reverse primer 
and 1X TaqMan Fast Advanced Mastermix (Applied Biosystems) amplified using the 
Prism7900HT sequence detection system (Applied Biosystems) and analysed with SDS 
(sequence detection systems) 2.4 software. All gene expression values were normalised to the 
housekeeping gene ubiquitin C, and relative expression calculated using the ΔΔCT method 
[51]. The efficiencies for all primers ranged from 81 – 120%. Significance of differences in 
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mRNA expression were examined through unpaired t-tests. Data show an average of three 
biological repeats. 
 
Immunocytochemistry  
MIN6 cells were seeded onto sterile glass coverslips and treated as described above. Cells were 
fixed using 4% paraformaldehyde for 15 min, permeabilised in 0.25% (v/v) Triton X-100 for 
10 min and blocked in 3% (w/v) BSA/PBS for 1 h. Cells were immunolabelled through 
incubation with primary antibodies targeting ZIP1 (SAB3500592; Sigma Aldrich), ZIP6 (PA5-
21071; Thermo Fisher), ZIP7 (19429-1-AP; Proteintech), ZIP9 (PA5-21074; Thermo Fisher) 
and ZIP14 (PA5-21077; Thermo Fisher) overnight at 4oC, followed by incubation with 
Alexafluor 595-linked secondary antibodies (A11012; Thermo Fisher) for 1 h at room 
temperature. Cells were extensively washed in PBS between each step. Coverslips were 
mounted onto coverslides using VECTASHIELD Antifade Mounting Media containing 4',6-
diamidino-2-phenylindole (DAPI) (VECTOR Laboratories) and imaged using an AR1 
confocal microscope (Nikon). We quantified the average Alexafluor 595 fluorescence 
intensities of six images taken across each slide using Fiji, ImageJ software [52], calculated as 
a ratio relative to DAPI. Significance of differences in protein abundances were examined 
through unpaired t-tests. 
 
Western blotting 
Protein lysates were prepared in 2x loading dye (Thermo Fisher) and boiled (10 min, 72oC). 
Lysates (20µg) were separated on 12% acrylamide SDS-PAGE gels using SDS-PAGE buffer 
(both Thermo Fisher) supplemented with 0.1% (w/v) SDS (200V, 40 min). Proteins were 
transferred onto nitrocellulose membranes [GE Healthcare Life Sciences (1 h, 100V)] using 
transfer buffer (25mM Tris, 192mM glycine, 10% methanol (pH 8.3)), and membranes blocked 
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through incubation in 5% (w/v) BSA/Tris-buffered saline [TBS (50mM Tris-Cl pH 7.5, 
150mM NaCl)] and 0.05% (v/v) TWEEN-20 [TBST (1 h, 25oC)]. Membranes were incubated 
with primary antibodies targeting ZIP1 [SAB3500592; Sigma Aldrich (1:400)] or α-Tubulin 
[T9026, Sigma (1:15,000)] diluted in 1% BSA/TBST (16 h, 4oC), followed by HRP-linked 
secondary antibodies [α-mouse: Amersham, NA931V (1:20,000); α-rabbit: Amersham, 
NA934V (1:15,000)] diluted in 1% BSA/TBST (1 h, 25oC). Membranes were extensively 
washed with TBST between each step. Membranes were treated with ECL Western Blotting 
Detection Reagent (GE Healthcare Life Sciences) and visualised on X-ray film (GE Healthcare 
Life Sciences) using a film imager. For membrane stripping, immunoblots were washed in 
TBST, incubated in stripping buffer [Thermo Fisher (15 min, 25oC)] and washed with TBST 
(10 min, 25oC). Membranes were blocked with 5% (v/v) BSA/TBST (1 h, 25oC) before further 
antibody incubation. 
 
Proliferation assays  
The rate of cell proliferation was determined using the Cell Proliferation ELISA, BrdU 
(colorimetric) assay (Roche), following manufacturer’s instructions.  
 
Apoptosis assays  
The rate of cell apoptosis was determined through Caspase-Glo® 3/7 assays (Thermo Fisher), 
following manufacturer’s instructions.  
 
Transcription factor network analysis 
MetaCore (GeneGo) Bioinformatics software from Thomson Reuters 
(https://portal.genego.com/) was used to create a network from qPCR data of transcription 
factor expression after zinc depletion for 48 h. The experimental data were uploaded to 
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MetaCore version 6.32 build 69020 and analysed through the ‘Build Network’ function, 
generating sub-networks enriched with the seed nodes from the qPCR data using canonical 
pathways and limiting the number of nodes in a network to 50. The top network was pruned to 
remove all objects with less than three links to analysed genes, leaving only FOXA2 (HNF-
3B) in addition to the analysed genes. Data showing the basis of this network are provided in 
Additional file 2.   
 
Results  
Prolonged stimulation decreases the total zinc content of MIN6 cells 
Zinc is co-released with insulin from β-cells during stimulation with glucose- or KCl–induced 
depolarisation. However, the consequences of prolonged stimulation for β-cell zinc content 
remain poorly understood. We stimulated MIN6 cells for 24 h and found a 2.8-fold depletion 
in total cellular zinc (Fig 1A). Total cell zinc depletion was associated with elevated mRNA 
expression of the metallothioneins Mt1 and Mt2 (1.3-fold and 2.1-fold, respectively, at 4 h and 
2.9-fold and 1.9-fold, respectively, at 24 h), indicative of an increase in cytosolic Zn2+ and 
consequent MTF1-mediated transactivation [53]. We further noted down-regulation of mRNA 
for Mtf1 1.4-fold at 4 h and 1.8-fold at 24 h (Fig 1B). 
 
Prolonged stimulation disrupts expression of multiple β-cell ZIP transporters  
Increased zinc uptake during β-cell stimulation is likely influenced by changes in activity 
and/or abundance of ZIP and ZnT paralogues important for β-cell function. We therefore 
explored protein and mRNA expression of ZIP paralogues we previously highlighted as 
important for β-cell function [46] and mRNA expression for ZnT1 and ZnT8. We identified 
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up-regulation of ZIP1 protein (1.5-fold) and a small but statistically significant down-
regulation of ZIP7 protein (1.1-fold) through immunocytochemistry following 24 h sustained 
stimulation (Fig 2A-B). ZIP1 protein up-regulation was verified using western blot (p=0.04) 
(Fig 2C). Whilst we did not observe any differences in the mRNA abundances for these 
paralogues at 4 h, mRNA for Slc39a1 and Slc39a7 showed statistically significant down-
regulation (Slc39a1: 6.8-fold, Slc39a7: 2.0-fold) along with those for Slc39a6 (2.3-fold), and 
Slc39a14 (2.2-fold) at 24 h (Fig 2D). We further observed statistically significant down-
regulation of mRNA for Slc30a8 (1.8-fold) at 24 h, but mRNA for Slc30a1 remained 
unchanged. These data suggest prolonged β-cell stimulation induces initial up- and down-
regulation of ZIP1 and ZIP7 proteins, respectively, followed by downregulation of mRNA for 
ZIP1, ZIP6, ZIP7, ZIP14 and ZnT8. 
  
Prolonged stimulation disrupts expression of zinc-responsive β-cell markers 
β-cell proliferation and function are controlled by multiple transcription factors, many of which 
are required to maintain the β-cell phenotype. Changes in the expression/function of important 
β-cell proteins are suggestive of loss of cellular identity and indicate mechanisms contributing 
to β-cell dedifferentiation [18,54]. We examined the expression of the transcription factors 
Foxa1, Foxo1, Hnf1b, Hnf4a, MafA, Mnx1, Neurod1, Nkx2.2, Nkx6.1, Pax4, Pax6 and Pdx1 in 
MIN6 cells following stimulation with KCl for 24 h and found significant up-regulation of 
mRNA expression for Hnf1b 2.9-fold, and down-regulation of mRNA expression for Foxa1 
(1.8-fold), MafA (3.8-fold), Mnx-1 (2.6-fold), Nkx2.2 (2.6-fold) and Pax6 (2.7-fold) (Fig 3A). 
Although not statistically significant, mRNA for Hnf4a showed 3.1-fold numerical increase 
(p<0.2) and Neurod1 2.0-fold decrease (p<0.06). These data indicate an association between 
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prolonged stimulation and changes in expression of key β-cell transcription factors with the 
predominant trend being down-regulation. 
 
The transcription factors NEUROD1, HNF1B, HNF4A, FOXA1, NKX2.2 and PAX6 have 
previously been identified as zinc-responsive [34-37]. Since prolonged stimulation decreases 
intracellular zinc content, we asked whether changes in β-cell transcription factor expression 
may be consequential of cellular zinc depletion. We treated MIN6 cells with growth medium 
containing low (1µM) zinc for 24 h to show no differences in mRNA expression for these key 
transcription factors compared to control cells cultured in growth medium with 8µM zinc (Fig 
3B). However, after 48 h we observed statistically significant down-regulation of mRNA for 
Hnf1b (3.3-fold), Hnf4a (2.9-fold), MafA (1.8-fold), Mnx-1 (3.6-fold), Nkx2.2 (1.2-fold), 
Nkx6.1 (2.5-fold) Pax4 (1.5-fold) Pax6 (3.2-fold) and Pdx1 (2.7-fold) (Fig 3C). These data 
demonstrate loss of Hnf1b, Hnf4a, MafA, Mnx-1, Nkx2.2, Nkx6.1, Pax4, Pax6 and Pdx1 in 
response to zinc depletion in mammalian β-cells and suggest changes in expression following 
chronic stimulation may be a result of zinc depletion caused by prolonged zinc secretion in 
combination with down-regulation of zinc importers.  
 
Suppression of β-cell markers is suggestive of loss of β-cell identity and mass. To explore the 
biologically relevant consequences of zinc depletion-induced transcription factor down-
regulation we examined mRNA expression for Arx, which is activated to induce β-to-α-cell 
reprogramming [55], and MIN6 cell survival. We recorded a comparable increase in Arx 
mRNA abundance for cells cultured with 40mM KCl for 24 h and low (1µM) zinc for 48 h 
(4.0-fold and 2.9-fold, respectively). Although we did not observe any differences in MIN6 
cell proliferation or apoptosis following 48 h zinc depletion (data not shown), by 96 h, cells 
exhibited a 1.3-fold decrease in proliferation (p<0.05) and 1.4-fold increase in apoptosis 
AC
CE
PT
ED
 M
A
US
CR
IPT
14 
 
(p<0.005). These data support the contribution of chronic stimulation-induced MIN6 cell zinc 
depletion to loss of β-cell identity and decreased survival.   
 
Discussion  
Zinc depletion of MIN6 cell causes loss of β-cell markers 
Zinc is an inter- and intracellular signalling component, regulating almost all aspects of cellular 
function including gene expression. In the current study, we demonstrate the transcription 
factors Hnf1b, Hnf4a, MafA, Mnx-1, Nkx2.2, Nkx6.1, Pax4, Pax6 and Pdx1 are down-regulated 
by zinc depletion in mammalian β-cells. These transcription factors have important roles in 
maintaining β-cell identity and their deregulation impacts cellular phenotype and function, 
including insulin pathway regulation, β-cell mass and islet architecture (Fig 4). PDX1 is 
considered the key transcription factor in mature β-cells mediating β-cell survival and mass 
[56] and controlling a large array of genes [57,58]. PDX1 [59], HNF4A [60], MAFA [61] and 
PAX6 [62,63] required for maximal insulin production. NKX6.1 stimulates islet cell 
proliferation [64], and MNX1 facilitates proliferation in aged cells [65]. Similarly, PAX4 
stimulates proliferation and promotes survival of mature β-cells through protecting against 
stress-induced apoptosis [66,67]. NKX2.2 acts upstream of GLUT2, the transporter responsible 
for glucose uptake into rodent β-cells, and is necessary for proper β-cell clustering and islet 
architecture [68], and HNF1B regulates pathways mediating glucose signalling in β-cells [69]. 
Critically, monogenetic mutations in Hnf1b, Hnf4a, Pdx1 and Pax4 result in ‘maternity-onset 
diabetes of the young’ (MODY) [70] and, recently, mutations in Nkx2.2 and Mnx-1 have 
additionally been linked to the neonatal disease [71]. Consistent with our results, hnf1ß, hnf4α, 
nkx2.2, and pax6 exhibit zinc-responsive expression in zebrafish [34-37], and PDX1 and PAX4 
show up-regulation in response to zinc in human exfoliated deciduous tooth stem cells 
induced into insulin-secreting β-cell like stem cells [38]. Importantly, β-cell and glucagon-
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secreting α-cells are derived from common progenitors and share expression of many 
transcription factors at differing equilibrium, many of which are specific to the endocrine 
pancreas; suppression of important β-cell transcription factors induces β-cell dedifferentiation 
and transdifferentiation into α-cells. PDX-1, NKX2.2 and NKX6.1 are essential for 
maintaining β-cell phenotype in early β-cell development, proceeded by a prominent role of 
PAX4, MAFA and the related transcription factor MAFB. In mature β-cells, loss of PDX-1 and 
NKX2.2 causes complete loss of β-cell identity and PAX4, NKX6.1 and PDX-1 inhibit 
glucagon expression to prevent α-cell transdifferentiation [54,72]. Concurrently, we 
demonstrate MIN6 cell zinc-depletion increases mRNA expression for Arx, which is indicative 
of loss of β-cell identity and α-cell reprogramming, and reduces MIN6 cell mass through both 
reduced proliferation and increased apoptosis. Our data further suggest the systemic 
hypozincaemia present in some type 2 diabetic patients may contribute to loss of β-cell mass 
through promoting β-cell dedifferentiation or transdifferentiation into α-cells.  
 
Prolonged stimulation of MIN6 cells causes zinc depletion and deregulation of β-cell markers  
Chronic hyperglycaemia elevates the requirement for zinc replenishment through extending 
the duration of secretory pathway activation and β-cell zinc loss. Following prolonged MIN6 
cell stimulation, we observed down-regulation of Foxa1, MafA, Mnx-1, Nkx2.2 and Pax6. We 
also found that a massive amount of the cellular zinc was lost during this treatment, probably 
reflecting the zinc lost from insulin granules, which has been previously observed following 
chronic exposure of rat INS-1E cells to high extracellular glucose [73]. Since depletion of zinc 
from the culture medium caused down-regulation of mRNA for nine out of the 12 β-cell 
markers measured, including MafA, Mnx-1, Nkx2.2 and Pax6, suppressed expression of these 
genes following prolonged stimulation may be a direct result of zinc depletion. The effects on 
β-cell markers were apparent following 24 h of KCl-induced depolarisation, but only after 48 
AC
CE
PT
ED
 M
AN
US
CR
IPT
16 
 
h of treatment with reduced zinc concentration in the culture medium. This difference in time-
course of the effect might be explained by temporal differences in depleting the cellular zinc 
content, which was very rapid during KCl treatment. However, treatment with a low zinc 
concentration in the culture medium did not completely mimic the effect triggered by 
prolonged stimulation using KCl. Interestingly, we show that depletion of zinc from the 
medium down-regulates Hnf1b. However the mRNA for this transcript was up-regulated 
following 24 h KCl stimulation; a similar relationship was observed for Hnf4a which was 
downregulated by zinc depletion for 48 h but not by the 24 h KCl-induced stimulation. Like 
most β-cell markers, expression of both Hnf1b and Hnf4a is tightly regulated by multiple 
factors, and an alternative pathway likely dominates regulation during cellular stimulation. 
Nevertheless, since major differences in Hnf1b and Hnf4a expression profiles are reported 
between healthy human and rodent cells [74], these results may not be easily translatable to the 
human Type 2 Diabetes.  
 
The role of zinc in maintenance of key transcription factors in MIN6 cells 
Complex coordination and cross-regulation exist between transcription factors to tightly 
regulate β-cell phenotype and function. Based on published interactions between these 
transcription factors and our experimental data showing zinc depletion-mediated changes in 
gene expression, we are able to speculate zinc might target this network at MAFA, NEUORD1 
or NKX2.2 (Fig 5). Zinc may influence changes in gene expression via MTF-1 or another zinc-
signalling pathway such as via the zinc-finger transcription factors KLF4 [75] or ZNF658 [76]. 
Alternatively, the results may stem from altered transcription factor phosphorylation affecting 
protein activation and/or localisation, which has been previously shown for MAFA [77] and 
NEUROD1 [78]. Pinpointing the molecular action of zinc in this network requires further 
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investigation and could prove important for understanding loss of β-cell identity and insulin 
secretory function during hyperglycaemia-induced β-cell dedifferentiation.  
 
Fluctuations in markers for cytosolic Zn2+during β-cell stimulation 
Cellular zinc depletion was accompanied by up-regulation of mRNA expression for the 
metallothioneins Mt1 and Mt2, which is suggestive of an early surge in cytosolic Zn2+ [40] 
followed by increased buffering capacity as MT1 and MT2 proteins are produced [79]. An 
early surge in Zn2+ uptake might be explained by increased zinc trafficking to insulin granules. 
We further demonstrated a decrease in mRNA expression for MTF1 within MIN6 cells, which 
cannot be readily explained. Zn2+ binds MTF1 at six Cys2His2-type zinc-finger domains, which 
exhibit differing binding affinities. Zn2+ binding promotes translocation of MTF1 from the 
cytosol to the nucleus, where MTF1 binds metal-response elements (MRE) in the promoters of 
zinc-regulated genes [80]. Although MTF1 transcript and protein levels increase with zinc 
treatment, MTF1 activity is mainly believed to be regulated post-translationally through 
nuclear-cytoplasmic shuttling, DNA-binding, phosphorylation and interaction with other 
transcriptional co-activators [13]. The observed increases in Mt mRNA could be a result of 
epigenetic regulation, increased MTF1 post-translational activation, or MTF1-independent 
mechanisms governing MT gene expression [81].  
 
Stimulation-induced increases in cytosolic  Zn2+ are consistent with a previous study on mouse 
islets [40], however these authors observed MT1 and MT2 decrease and did not assess the total 
cellular zinc content. This variation could be explained by differences in the experimental 
design, including use of glucose rather than KCl to induce cellular stimulation or the use of 
primary islets containing 70-80% β-cells rather than a β-cell line which exist as a monolayer. 
We acknowledge that it is possible these differences in results could be an artefact of tissue 
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culture rather than a physiological response, but our observations would still lend valuable 
information for interpreting future data on changes to the zinc status of β-cells. Furthermore, 
the variation may only represent temporal differences between conditions, perhaps influenced 
by the time required to induce intracellular zinc depletion. These observations need to be 
explored further to distinguish between physiological state and the pathological state 
proceeding loss of β-cell identity and β-cell dedifferentiation. 
 
Regulation of zinc transporter expression during prolonged stimulation of MIN6 cells 
L-VGCCs are activated during stimulation of the insulin secretory pathway [28] but are not 
thought to play the pivotal role in cellular zinc uptake [40], indicating important roles for the 
ZIP transporters. Our results suggest that an early post-transcriptional or post-translational up-
regulation of ZIP1 protein may be integral in the physiological response to increased 
stimulation in murine MIN6 cells. ZIP1 is a plasma membrane-bound paralogue which we 
previously identified as highly expressed and potentially biologically important for rodent but 
not human β-cells [46]. It is therefore possible human β-cells encompass a different mechanism 
from rodents to adapt to increased zinc replenishment during elevated insulin secretion, perhaps 
through up-regulating expression of transporters functionally substituting in β-cells for the 
rodent ZIP1. Contrary to our expectation of what would happen following KCl-induced cellular 
zinc depletion, we observed down-regulation of Slc39a1, Slc39a6, Slc39a7 and Slc39a14 
mRNA after 24 h KCl stimulation. This could be in response to elevations in cytosolic Zn2+, 
either representing a protective mechanism to prevent cytosolic Zn2+ accumulation to 
pathological concentrations or reflecting zinc-responsive changes to mRNA transcript levels. 
Down-regulation of mRNA for ZIP4, ZIP5, ZIP6, ZIP7 and ZIP10 has previously been 
identified as a mechanism to protect against cytosolic zinc overload [41,42,82,83]. ZIP7 is 
localised to the Golgi apparatus [42], which stores zinc at high concentrations [84], and 
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functions to release zinc spatially and temporally in response to stimuli [42]; ZIP7 down-
regulation could be indicative of zinc depletion from the Golgi apparatus or represent a 
protective mechanism to prevent further depletion. Furthermore, ZIP14 facilitates import of 
non-haem iron in addition to zinc [85,86], indicating stimulation-induced ZIP14 
downregulation could be a protective mechanism against accumulation of iron to cytotoxic 
concentrations. It is possible the observed ZIP suppression is simply a pathological response 
to prolonged stimulation rather than serving a physiological purpose. Since ZIP6, ZIP7 and 
ZIP14 additionally exhibit potent roles in stimulating cellular proliferation [87-92], chronic 
stimulation is likely to be detrimental to β-cell proliferation, and this may help to explain the 
loss of β-cell mass observed in type 2 diabetic patients.  
 
ZnT transporters likely function co-operatively with the ZIPs to mediate β-cell zinc trafficking 
in response to chronic stimulation. A recent study has reported appreciable expression of all 
ZnT exporters in pancreatic β-cells [93]. Of potential notable importance, ZnT1 is detected 
with high abundance at the plasma membrane and ZnT8 at the insulin granule membranes. We 
demonstrate Slc30a8 mRNA downregulation in MIN6 cells following 24 h KCl stimulation. 
ZnT8 downregulation has been suggested to increase β-cell survival [94,95]; however, studies 
using rat INS-1E cells demonstrate repression reduces cellular insulin content and GSIS[96] 
and overexpression stimulates increase in total intracellular zinc and protects against zinc-
depletion induced cellular death [97], indicating loss of ZnT8 reduces β-cell identity and 
survival. Accordingly, there is currently no clear consensus on the role of ZnT8 for β-cell 
phenotype and function. There was no observed difference in mRNA expression for ZnT1. 
ZnT1 is regulated by MTF1 [98] and dietary zinc [99] at the transcriptional, post-transcriptional 
and post-translational level, including through presumed subcellular redistribution [100], and 
knockdown increases cadmium influx and toxicity [101]. We are therefore unable draw 
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conclusions about ZnT1 regulation in response to chronic MIN6 cell stimulation from our data 
without first exploring the abundance and subcellular localisation of the expressed protein.  
 
Conclusion  
In this study, we explored the consequences of prolonged β-cell stimulation, characteristic of 
the hyperglycaemia universal in type 2 diabetic patients, for cellular zinc status and markers of 
β-cell function. We show sustained stimulation depletes β-cells of zinc and down-regulates 
multiple ZIP transporters of importance for β-cell function [46]. Potentially important for 
understanding human Type 2 Diabetes development, we demonstrate key β-cell transcription 
factors disrupted by prolonged stimulation are zinc-responsive in mammalian β-cells and their 
mRNA levels depressed by zinc depletion. We further anchored these findings to β-cell 
function, by showing that zinc depletion decreases proliferation and increases apoptosis. 
Critically, our results reveal a plausible causative link between hyperglycaemia-induced zinc 
depletion of pancreatic β-cells and loss of expression of transcription factors of importance for 
β-cell differentiation, proliferation and endocrine function.  
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Figure legends  
 
Fig 1. MIN6 cell zinc content following prolonged stimulation. (A) Total cellular zinc 
content after 24 h treatment with 40mM KCl determined through ICP-MS and normalised to 
protein content. N=4. (B) mRNA expression of Mt1, Mt2 and Mtf1, assessed through qPCR. 
Expression was calculated as a ratio compared to cells cultured under the same conditions but 
without KCl (3mM glucose; control). N=3. Error bars show ±SEM. *p<0.05, **p<0.005, 
***p<0.001. 
 
Fig 2. Changes in ZIP/Slc39a expression in MIN6 cells following prolonged stimulation. 
(A-C) ZIP protein abundances following culture with 40mM KCl for 24 h, imaged by 
immunocytochemistry. (A) Representative immunocytochemistry images for ZIP1 and ZIP7 
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after 24 h. Scale bar: 100µm. (B) Average changes in ZIP protein abundances after 24 h. (C) 
Western blot for ZIP1 protein abundance after 24 h. (D) Slc39a mRNA abundances following 
culture with 40mM KCl for 4 h (grey) and 24 h (black), assayed through qPCR. Expression 
was calculated as a ratio compared to cells cultured under the same conditions but without KCl 
(3mM glucose; control). N=3. Error bars show ±SEM. *p<0.05, **p<0.005, ***p<0.001. 
 
Fig 3. Changes in mRNA expression of transcription factors in MIN6 cells. (A) Expression 
in response to stimulation with 40mM KCl for 24 h. Expression was calculated as a ratio 
compared to cells cultured under the same conditions but without KCl (3mM glucose; control).  
(B-C) Expression in response to extracellular zinc depletion for (B) 24 h or (C) 48 h. 
Expression was assayed through qPCR and calculated as a ratio compared to cells cultured 
with 8µM extracellular zinc (control). N=3. *p<0.05, **p<0.005. 
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Fig 4. Schematic illustrating key roles of the zinc-responsive transcription factors in 
mature β-cells. All transcription factors shown are down-regulated in response to zinc 
depletion in MIN6 cells. Transcription factors highlighted in orange show down-regulation in 
response to prolonged stimulation with KCl and those highlighted in green show up-regulation 
in response to prolonged stimulation with KCl. The arrows represent known signal transduction 
pathways between the transcription factors in β-cells.  
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Fig 5. Network of interactions between the transcription factors FOXA1 (HNF3A), 
FOXA2 (HNF3B), FOXO1 (FKHR), HNF1B, HNF4A, MAFA, MNX1 (HB9), NEUROD1, 
NKX2.2, NKX6.1, PAX4, PAX6 AND PDX1 in β-cells. The pathways highlighted in blue 
are the ‘nodes’ considered to drive the network in response to zinc. The red circles indicate the 
respective gene is up-regulated and the blue circles indicate the respective gene is down-
regulated in response to zinc. Created using GeneGo MetaCore Bioinformatics software from 
Thomson Reuters (https://portal.genego.com/). Data showing the basis of this network are 
provided in Additional file 2.   
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